4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-23-025763
Chief Medical Officer sold 14,400 shares at $103.48 ($1,490,059)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROBERTS EIRY · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-24 | Sale : show line 1 in the form 10b5-1 | −14,400 | $103.48 | $1,490,059 | 26,644 | D |
| Open-market sales · 14,400 sh · avg $103.48 · $1,490,059 | ||||||
Loading xslF345X04/doc4.xml…